USE OF FORMOTEROL IN THE PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF MUSCLE WASTING AND/OR CACHECTIC SYNDROME WHICH ARE ASSOCIATED WITH CATABOLIC CONDITIONS OF CERTAIN DISEASES, SUCH AS CANCER, AIDS, INFECTIONS, DIABETES AND OTHERS

摘要

Formoterol, used until now for the treatment of bronchospasm associated with asthma, exhibits a powerful anti-cachectic efficiency with relatively low adverse side effects and toxicity. Thus, the invention relates to the use of formoterol or their pharmaceutically acceptable salts or solvates, particularly fumarate or fumarate dihydrate, for the preparation of a medicament for the prophylactic and/or therapeutic treatment of muscle wasting and/or a cachectic syndrome, both associated to a catabolic state in a mammal, in particular a human. Some catabolic states to be treated with formoterol are cancer, acquired immune deficiency syndrome (AIDS), sepsis, diabetes, immobilization states or muscle distrophies.